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Dr Erle H. Austin III (Louisville, Ky). I have no disclosures.
I congratulate Dr Hasaniya on an excellent presentation and
thank him for providing me with the manuscript and slides to
help me prepare these comments. I also thank Dr Bailey and his
colleagues for introducing this technique back in the mid-1990s.
Although I am aware that Dr Hvass should be credited with the
pedicle pericardial tube concept, the Loma Linda group modified
the technique to use the atrial epicardium as the medial wall of the
extracardiac pathway and began to apply this technique to the vast
majority of their Fontan candidates.
Back in 1995, when the extracardiac conduit idea was begin-
ning to catch on, I began to convert to the polytetrafluoroethylene
tube technique. My enthusiasm for that approach, however, signif-
icantly waned when I almost lost a patient on the second postoper-
ative day when the polytetrafluoroethylene conduit acutely
thrombosed. After that unsettling experience, I was seriously con-
sidering reverting to the lateral tunnel when I heard Dr Steve Gun-
dry, who was Len Bailey’s associate at the time, describe this idea
of using the patient’s own viable vascularized in situ pericardium
to construct the Fontan pathway. As this seemed to me at the time
to be much less likely to pose a thrombosis risk, I soon tried the
approach myself, and it has been the technique I have used most
commonly ever since. My experience is somewhat more modest
in terms of numbers and length of follow-up, having reported
our 7-year experience back in 2004, but it has essentially matched
the excellent results that you have presented today. I am especially
pleased to see that your 10-year overall survival is as good as any
other reported series of Fontan operations. However, as suggested
in Sunday morning’s congenital symposium, we may need at leastdiovascular Surgery c Volume 140, Number 5 1081
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currently applied Fontan techniques proves to be the superior one.
Like you, with the extracardiac pedicle pericardial approach, I
have rarely found it necessary to perform fenestration in these pa-
tients. I have learned that in some cases it is necessary to augment
the pericardial flap with some bovine pericardium to avoid any nar-
rowing of the pathway, especially over the pulmonary veins. Un-
like you, however, I have not felt the need to cool substantially
on bypass and have thus usually been able to complete the con-
struction of the pathway in less than an hour of bypass time. The
excellent early postoperative course in your patients, however, sug-
gests that extra time on bypass had minimal if any adverse effect.
Despite what we consider to be enviable results, you did have
a few problems, specifically with the created extracardiac tunnel.
You indicated in the presentation and in the manuscript that 3 pa-
tients had pathway stenosis that was attributed to technical error. I
do think that this technique is slightly more technically demanding
than simply sewing in 2 ends of a tube graft and that may explain
why relatively few surgeons have tried this technique.
My first question, therefore, is this: Can you describe the tech-
nical errors that were encountered and what technical pitfalls your
mentors may have taught you to avoid when you perform this
novel technique?
Dr Hasaniya. Thank you, Dr Austin, for taking the time to re-
view our manuscript and thank you for your questions.
Of course, I joined the team at Loma Linda approximately 5
years ago, and so I avoided these pitfalls. There are a few important
points: We are operating close to the phrenic nerve, but it really is
not necessary to dissect close to the phrenic nerve, except some-
times inferiorly, and that must be done carefully to release the peri-
cardium. As I showed, we did not have any nerve injury on the side
of Fontan.
The other important point is not to make the tunnel really big. If
you need to trim the pericardium, you need to do so tomake the tun-
nel diameter equal or slightly bigger than the diameter of the IVC.
Most of these technical errors happened in our early experience;
they happened mainly in the IVC junction. However, we have not
experienced any of these in the last probably 7 to 9 years. This
could be attributed to Dr Bailey’s modification of suturing the peri-
cardial flap to the diaphragm (not to the IVC edge) to avoid steno-
sis at that anastomosis.
Dr Austin. In my own learning experience, the IVC area was
the area that was of greatest concern. I did find that if you are
not careful, you can create a twist in the pathway when you place
the clamp to oversew the atrial side of the IVC–atrial junction. If
you do not place the clamp in a straight anteroposterior orientation,
you can get a twist and narrowing at that particular point.
Dr Hasaniya. That is probably the advantage of hypothermia
because that allows us not to use any clamps on the IVC; we just
use a flexible sucker in the IVC and everything is wide open. We
usually match the medial part with a stay suture before we com-
plete the anterior anastomosis.
Dr Austin. My second question relates to fenestration. I know
that it was rarely performed in your experience, but you do need
to be prepared to perform it. If you find yourself in that situation,
how exactly would you perform it?
Dr Hasaniya. Intraoperatively, you can use a punch before
closing the tunnel into the side of the right atrial wall to create1082 The Journal of Thoracic and Cardiovascular Surthe fenestration. The advantage of this technique is you can do it
after surgery as well. This technique allows you to take the patient
to the cardiac catheterization laboratory and pass a guidewire
puncture through the right atrium and then create the fenestration.
Dr Austin. Did you ever do that?
Dr Hasaniya. Yes, we have done it in 1 patient.
Dr Austin. Just to add to your response, we had a patient in
whom protein-losing enteropathy developed within a year of this
operation. Echocardiography and catheterization showed a very
competent pathway, and so there was not a problem with the
tunnel. However, we were able to perforate the atrial wall in the
catheterization laboratory, creating a fenestration and actually im-
proving the protein-losing enteropathy, so that is an advantage to
this technique of extracardiac Fontan.
Finally, what are your current preferred age and weight criteria
for performing this operation? Since you have confirmed in at least
10 patients that the in situ pedicle extracardiac conduit grows with
the patient, do you think that it is necessary to wait for the patient
to reach a certain size before proceeding to the Fontan operation as
some surgeons do when placing a conduit that does not have
growth potential?
Dr Hasaniya. That is an excellent question. As you mentioned,
the growth potential has been documented also by other reports in
the literature. Because of that, in the past 7 or 8 years, we have per-
formed the Fontan operation around 2 years of age in most of our
patients, unless there is some other contraindication. If we do an
age analysis, the majority of the patients at present undergo the
Fontan operation around 2 years of age.
Dr Austin. Is there something special about 2 years, or is that
just because everybody else does it that way?
DrHasaniya. That is what we do. We do have a small subgroup
of children under age 2 (18–22 months) who had completion Fon-
tan with good outcomes. This technique allows for completion
Fontan at a younger age. In fact, a smaller sized child may be
advantageous and easier to treat with shorter cardiopulmonary by-
pass time, less time to cool, and shorter time to rewarm. Yes, this is
a definite advantage of the technique.
Dr Austin. Again, my congratulations to you and your coau-
thors for developing and sticking with this innovative approach
to the Fontan operation.
Dr James S. Tweddell (Milwaukee, Wis).You said in your con-
clusion that this technique adapts to flow dynamics. Can you ex-
pand on that a little bit? What did you mean precisely by that?
Dr Hasaniya. If you look at the diameter of the tunnel at the
IVC junction and the mid tunnel, when we measured that over 3
years, in some of these patients the diameter increased, some of
them stayed the same, and some of them became smaller. As
you know, when you create the tunnel it is done by eyeballing,
so the tunnel does either increase, decrease, or not change, depend-
ing on the flow demands. This is why when we index that to the
body surface area, we get a flat line.
Dr Tweddell. I see. And your hospital length of stay was laud-
ably short, 4.2 days. That is really fantastic, but about 20% of the
patients were readmitted. Did you look at that group of patients to
determine why they were readmitted?
DrHasaniya.We are in the process of studying these patients. I
know that in a few reported series, the hospital stay is usually
around 10 days or more. What we have been adopting in recentgery c November 2010
Hasaniya et al Congenital Heart Diseaseyears is to send these patients home with a Blake drain on the right
side, and we teach the parents to record the output daily. We ob-
serve them as outpatients until the drainage is low, and then we
take drain out as outpatients.
Dr Tweddell.What percentage of patients were sent home with
a drain in?
Dr Hasaniya. Nowadays, close to 100% are sent home with
a Blake drain in place.The Journal of Thoracic and CarDr Ayman Abdul-Ghani (Anniston, Ala). Congratulations on
your study. Why did you study only 10 patients for the growth
pattern?
DrHasaniya. The reasons were lack of time and lack of money.
We did not have money to pay the technician to really analyze
more than 10 patients. These patients had several echocardiograms
done. We selected whatever could be done by the technician and
we did the analysis on these 10 patients.diovascular Surgery c Volume 140, Number 5 1083
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